To Evaluate the Efficacy and Safety of SAL056 for Postmenopausal Women With Osteoporosis at High Fracture Risk
Clinical trial NCT07028320 · COMPLETED
Trial details
- NCT number
- NCT07028320
- Sponsor
- Shenzhen Salubris Pharmaceuticals Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-12-30
- Enrollment
- 493
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.